Guided Therapeutics (GTHP) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Guided Therapeutics (GTHP) over the last 9 years, with Q3 2025 value amounting to -$69000.0.
- Guided Therapeutics' Other Gross PP&E Adjustments rose 5792.68% to -$69000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$69000.0, marking a year-over-year increase of 5792.68%. This contributed to the annual value of -$141000.0 for FY2024, which is 6961.21% up from last year.
- Per Guided Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$69000.0 for Q3 2025, which was up 5792.68% from -$94000.0 recorded in Q2 2025.
- Over the past 5 years, Guided Therapeutics' Other Gross PP&E Adjustments peaked at -$69000.0 during Q3 2025, and registered a low of -$481000.0 during Q4 2022.
- In the last 5 years, Guided Therapeutics' Other Gross PP&E Adjustments had a median value of -$285000.0 in 2023 and averaged -$280210.5.
- Per our database at Business Quant, Guided Therapeutics' Other Gross PP&E Adjustments tumbled by 53606.56% in 2021 and then surged by 6961.21% in 2024.
- Guided Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$372000.0 in 2021, then dropped by 29.3% to -$481000.0 in 2022, then increased by 3.53% to -$464000.0 in 2023, then soared by 69.61% to -$141000.0 in 2024, then surged by 51.06% to -$69000.0 in 2025.
- Its Other Gross PP&E Adjustments was -$69000.0 in Q3 2025, compared to -$94000.0 in Q2 2025 and -$118000.0 in Q1 2025.